Pfizer's Covid vaccine effectiveness claims inject hope, lift global stocks

Firms hit hardest by restrictions made most gains, with airlines trading 30% higher

Coronavirus, vaccine, covid, drugs, clinical trials
The S&P 500 and the Dow hit record highs on Monday as the first successful late-stage clinical trial of a Covid-19 vaccine sparked hopes of the economy emerging from a pandemic-driven crisis
Rita Nazareth & Vildana Hajric | Bloomberg
3 min read Last Updated : Nov 10 2020 | 1:08 AM IST
Stocks surged around the world and bonds tumbled after a large-scale coronavirus vaccine study delivered the most-promising results in the battle against the worst pandemic in a century.

Equities came off session highs after Mayor Bill de Blasio said New York City is coming “dangerously close” to a second wave of the coronavirus. 

Still, more than 85 per cent of S&P 500 companies climbed on Monday as the gauge jumped to a record on news that the Covid-19 shot being developed by Pfizer and BioNTech prevented more than 90 per cent of infections. 

The S&P 500 and the Dow hit record highs on Monday as the first successful late-stage clinical trial of a Covid-19 vaccine sparked hopes of the economy emerging from a pandemic-driven crisis.

The blue-chip Dow surged as much as 5.7 per cent, also getting a boost from Joe Biden clinching a tightly-fought presidential election.

The companies hit hardest by months of travel bans and lockdowns soared, with Boeing Co up 12.6 per cent and airlines and cruise line operators all trading 20 per cent to 30 per cent higher. 


Shares that have been hit hard by the economic toll of lockdowns such as small caps, travel stocks and movie theaters soared, with Carnival and Cinemark Holdings surging more than 35 per cent. 

Stay-at-home companies Zoom Video Communications and Peloton Interactive plunged at least 16 per cent on hopes that a return to normal is on the horizon. Online giant Amazon.com retreated.

A credit derivatives index that measures the perceived risk of high yield dropped by the most in seven months, with junk-rated companies hitting the market in droves to take advantage of a plunge in borrowing costs. Oil soared, while gold, the Japanese yen and the Swiss franc slumped.

Investors pulled out of haven assets and poured cash into markets that are closely tied to economic growth, with a gauge of global stocks also hitting a record high.  President-elect Joe Biden on Monday announced a new coronavirus task force as his transition team seeks to fulfill a campaign promise to develop a dramatically different approach than President Donald Trump’s to contain the pandemic. The top infectious disease expert in the US Anthony Fauci said the vaccine being developed by Pfizer will have a “major impact” on everything we do with regards to the coronavirus going forward.

“The bull market has a ton of ammunition to keep going,” said Chris Larkin, MD of trading at E*Trade Financial. “With more certainty around the election, a strong quarter of earnings across many sectors, and extremely positive news on the vaccine front, there is little to hold us back.”  

Elsewhere, the Australian dollar-yen cross — a commonly watched risk barometer — surged by most since June. The Turkish lira soared after the weekend resignation of the country’s economy czar and the dismissal of the central bank chief.


One subscription. Two world-class reads.

Already subscribed? Log in

Subscribe to read the full story →
*Subscribe to Business Standard digital and get complimentary access to The New York Times

Smart Quarterly

₹900

3 Months

₹300/Month

SAVE 25%

Smart Essential

₹2,700

1 Year

₹225/Month

SAVE 46%
*Complimentary New York Times access for the 2nd year will be given after 12 months

Super Saver

₹3,900

2 Years

₹162/Month

Subscribe

Renews automatically, cancel anytime

Here’s what’s included in our digital subscription plans

Exclusive premium stories online

  • Over 30 premium stories daily, handpicked by our editors

Complimentary Access to The New York Times

  • News, Games, Cooking, Audio, Wirecutter & The Athletic

Business Standard Epaper

  • Digital replica of our daily newspaper — with options to read, save, and share

Curated Newsletters

  • Insights on markets, finance, politics, tech, and more delivered to your inbox

Market Analysis & Investment Insights

  • In-depth market analysis & insights with access to The Smart Investor

Archives

  • Repository of articles and publications dating back to 1997

Ad-free Reading

  • Uninterrupted reading experience with no advertisements

Seamless Access Across All Devices

  • Access Business Standard across devices — mobile, tablet, or PC, via web or app

Topics :Coronavirus VaccinePfizerglobal stock market

Next Story